For example, CLC5 and CLC11 harbored amplification of 11q13 region containing CCND1-FGF19 and homozygous deletion of 16p13 containing AXIN1. CCNE1 was amplified in both CLC16 primary HCC and the matched cell line. The gene discussed is CCND1; the disease is hepatocellular carcinoma.